RecruitingNot ApplicableNCT06640751

The Effect of Interventions for Health Behaviors in Hypertensive Patients

The Effect of Interventions for Health Behaviors in Hypertensive Patients -Based on the PRECEDE-PROCEED Model

Sponsor

Nanjing Medical University

Enrollment

240 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Hypertension Health Behavior Public Health

Summary

Hypertension is a major risk factor for cardiovascular disease, chronic kidney disease, and premature death worldwide. With an aging population and changes in dietary patterns and lifestyles, the prevalence of hypertension is rising globally, especially in developing countries. Hypertension is the most common chronic disease and a growing public health problem in China. A recent study estimated the prevalence of hypertension to be 28.56 % ± 10.44 %, ranging from 14.28% to 44.28% among the Chinese population aged over 15 years. The PRECEED-PROCEDE model provides a framework to help health planners and policymakers design effective health interventions based on evaluation and analysis of situations. This model has been used in different recent studies related to behavioral change. The study aims to examine the effectiveness of interventions for health behaviors in hypertensive patients based on the PRECEDE-PROCEED model.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether targeted health behavior coaching and education can help people with mild to moderate high blood pressure better manage their condition and improve their health habits. **You may be eligible if...** - You are between 18 and 80 years old - You have been diagnosed with mild to moderate primary high blood pressure that is not well controlled or you have poor medication adherence - You can communicate normally and are willing to participate - You have lived in the community for at least 12 months **You may NOT be eligible if...** - You have significant memory impairment or limited ability to communicate - You are currently enrolled in another health intervention study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALHealth behavior intervention

The program is a group-based intervention provided by a healthcare team consisting of researchers, cardiologists, family doctors, community healthcare workers, psychologists, and health education specialists. The intervention is structured around three modules-predisposing, enabling, and reinforcing factors-that provide a framework for educational interventions aimed at promoting healthy behaviors in hypertensive patients.

Locations(1)

Community health service center

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06640751

Related Trials

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

NCT070644731152 locations

Hypertension Management in Young Adults Personalised by Echocardiography and Clinical Outcome.

NCT037624991 location